We further evaluated the diagnostic potential of circulating GDF3, which demonstrated that it could be a noninvasive diagnostic biomarker for NASH with high accuracy (AUROC = 0.90). This evidence concerns the gene GDF3 and metabolic dysfunction-associated steatohepatitis.